ATE258801T1 - Matrixprotein zusammensetzungen um apoptose zu induzieren - Google Patents

Matrixprotein zusammensetzungen um apoptose zu induzieren

Info

Publication number
ATE258801T1
ATE258801T1 AT00906552T AT00906552T ATE258801T1 AT E258801 T1 ATE258801 T1 AT E258801T1 AT 00906552 T AT00906552 T AT 00906552T AT 00906552 T AT00906552 T AT 00906552T AT E258801 T1 ATE258801 T1 AT E258801T1
Authority
AT
Austria
Prior art keywords
induce apoptosis
matrix protein
protein compositions
enamel matrix
apoptosis
Prior art date
Application number
AT00906552T
Other languages
English (en)
Inventor
Stale Petter Lyngstadaas
Lars Hammarstroem
Stina Gestrelius
Original Assignee
Biora Bioex Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biora Bioex Ab filed Critical Biora Bioex Ab
Application granted granted Critical
Publication of ATE258801T1 publication Critical patent/ATE258801T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00906552T 1999-03-10 2000-03-09 Matrixprotein zusammensetzungen um apoptose zu induzieren ATE258801T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199900336 1999-03-10
PCT/IB2000/000245 WO2000053196A1 (en) 1999-03-10 2000-03-09 Matrix protein compositions for induction of apoptosis

Publications (1)

Publication Number Publication Date
ATE258801T1 true ATE258801T1 (de) 2004-02-15

Family

ID=8092394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906552T ATE258801T1 (de) 1999-03-10 2000-03-09 Matrixprotein zusammensetzungen um apoptose zu induzieren

Country Status (8)

Country Link
EP (1) EP1162985B1 (de)
JP (1) JP2002538211A (de)
AT (1) ATE258801T1 (de)
AU (1) AU2821000A (de)
DE (1) DE60008077T2 (de)
DK (1) DK1162985T3 (de)
ES (1) ES2215027T3 (de)
WO (1) WO2000053196A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5095063B2 (ja) * 2000-06-20 2012-12-12 ストローマン ホールディング アーゲー 象牙質再生に用いる基質タンパク質組成物
EP1830863A2 (de) 2004-12-10 2007-09-12 Straumann Holding AG Proteinformulierung
SE0403014D0 (sv) 2004-12-10 2004-12-10 Straumann Holding Ag New protein formulation
WO2011051457A2 (en) 2009-11-02 2011-05-05 Straumann Holding Ag Purified emd protein composition
WO2011073447A1 (en) 2009-12-18 2011-06-23 Straumann Holding Ag Emd c-depleted
JP5671618B2 (ja) 2010-10-15 2015-02-18 ストラウマン ホールディング アーゲー Ｐｇａを含んでなる新しいｅｍｄ製剤
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672032A (en) * 1983-11-09 1987-06-09 University Of Southern California Dental enamel production

Also Published As

Publication number Publication date
ES2215027T3 (es) 2004-10-01
DE60008077T2 (de) 2004-12-23
DE60008077D1 (de) 2004-03-11
AU2821000A (en) 2000-09-28
EP1162985B1 (de) 2004-02-04
JP2002538211A (ja) 2002-11-12
WO2000053196A1 (en) 2000-09-14
EP1162985A1 (de) 2001-12-19
DK1162985T3 (da) 2004-06-14

Similar Documents

Publication Publication Date Title
BR9811956B1 (pt) naftiridinonas e composição farmacêutica compreendendo as mesmas.
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
HRP950337A2 (en) Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
HUP0400918A3 (en) Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases
TR200100054T2 (tr) Paroksetin metansülfonat
DE69427127D1 (de) Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
ATE556706T1 (de) Fettalkohol-arzneimittel-konjugate
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
NO20015516L (no) Preparater og anvendelser av ET743 for behandling av kreft
EA200200922A1 (ru) Композиция, включающая камптотецин и производное пиримидина, для лечения рака
DE60324431D1 (de) Derivate des 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazols als antagonisten des gonadotropin freisetzenden hormons (gnrh) zur anwendung in de behandlung von geschlechtshormonellen erkrankungen, wie prostata- oder gebahrmutterkrebs
PT1228097E (pt) Actividade antimicrobiana do primeiro grupo cationico da lactoferrina humana
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
DK1185279T3 (da) Midler til behandling af maligne sygdomme ved anvendelse af proteinet YB-1
ATE258801T1 (de) Matrixprotein zusammensetzungen um apoptose zu induzieren
NO993784D0 (no) Farmasöytiske blandinger inneholdende ibuprofen og domperidon for behandling av migrene
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
ZA986720B (en) Photoresponsive sunscreen compositions
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
ATE366720T1 (de) Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
CO4920227A1 (es) Histidina-n-bencil glicinamida sustituida con cicloalquilos .

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1162985

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee